Long-term Results After Transcatheter Aortic Valve Implantation: What do we Know Today?

ISSN: 1875-6557 (Online)
ISSN: 1573-403X (Print)

Volume 13, 4 Issues, 2017

Download PDF Flyer

Current Cardiology Reviews

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Jian'an Wang
School of Medicine Zhejiang University

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Long-term Results After Transcatheter Aortic Valve Implantation: What do we Know Today?

Current Cardiology Reviews, 9(4): 295-298.

Author(s): Y. Elhmidi, S. Bleiziffer, N. Piazza, B. Voss, M. Krane, M-A. Deutsch and R Lange.

Affiliation: German Heart Centre Munich, Lazarettestrasse 36, 80636, Munich, Germany.


Transcatheter aortic valve implantation (TAVI) is evolving rapidly as a therapeutic option in patients deemed to be at high risk for surgical aortic valve replacement. Early outcome and survival of controlled feasibility trials and single- center experience with TAVI have been previously reported. Valve performance and hemodynamics seem to improve significantly after TAVI. Long-term outcome up to 3 years have been demonstrated in recent studies. Admittedly, the results are encouraging with a survival rate at 2 and 3 years ranging from 62 to 74% and from 56 to 61% respectively. The improvement in hemodynamical and clinical status sustained beyond the 3 years follows up. However, paravalvular leakage after TAVI remains an important issue in this rapidely evolving field.


Aortic valve, TAVI, paravalvular leakage, aortic stenosis, SAVR.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
Issue Number: 4
First Page: 295
Last Page: 298
Page Count: 4
DOI: 10.2174/1573403X09666131202124227
Price: $58

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science